Healthcare
India's Max Healthcare bags $165m in fundraising round
Proceeds will be used partly for meeting the company’s capital spending.
India's Max Healthcare bags $165m in fundraising round
Proceeds will be used partly for meeting the company’s capital spending.
South Korea's healthcare exports jumped 38.3% in 2020
Medicine exports soared 62.6% to $8.43b during the period.
Stronger R&D focus in sight for Vietnam's pharmas
Most local pharma firms hold the research on new drugs as their predominant strategy.
Rise in ageing population and diseases drive APAC's MRI market
The population aged above 65 in China is projected to reach 247 million by 2030.
Ageing population to ramp up APAC's arrhythmia monitoring market
Heart disease cases in India are projected to hit 19.1 million by 2050.
Australia's implantable ports grow amidst rising cancer cases
There has been a growing need to control dosage of chemotherapy drugs.
Launch of generic oncology drugs underway in India
The government has approved generic versions of a kidney cancer drug.
TVM Capital Healthcare sells portfolio hospital
The hospital has a capacity of 250 beds plus out-patient facilities.
Malaysia's private hospitals to play bigger role in COVID-19 battle
The government is integrating public and private hospitals as the healthcare system is at its breaking point.
Rising social media use for homecare boosts APAC's elderly care market
The homecare segment is expected to dominate the market.
North Korea attempts to hack South Korean pharma
North Korea is looking to get information on the company’s COVID-19 vaccine and treatment.
APAC emerged as second largest market for hospitals, outpatient centres
China’s medical insurance schemes will help improve healthcare access in the country.
Infrastructure initiatives boost traditional Chinese medicine production
Demand for traditional Chinese medicine is rising in developed economies.
Fortis Memorial Research Institute launches pediatric tumor clinic
The clinic aims to treat children with a variety of solid tumors and cancers.
South Korea's biomedical R&D to flourish on state investment
Companies have also made investments in R&D as they shift away from generic drugs.
Indonesia's Gorry Holdings to invest in infrastructure expansions
The health tech firm will also invest in AI and machine learning.
Generic medications and Asia-Pacific health systems: A viable win-win-win strategy?
This article explains in greater detail the challenges faced by the generic drug manufacturing industry.